Cytomegalovirus and Epstein-Barr virus-acquired immunity after Sandoglobulin prophylaxis in the pediatric renal transplant population.
Ham
J M
JM
Department of Vascular and Transplant Surgery, Medical College of Virginia, Richmond 23298-0057.
Bunchman
T E
TE
Campbell
D A
DA
Kershaw
D B
DB
Punch
J D
JD
Sedman
A B
AB
Turcotte
J G
JG
Merion
R M
RM
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D003587:Cytomegalovirus / Q000276:immunology*; D003586:Cytomegalovirus Infections / Q000276:immunology / Q000517:prevention & control; D006566:Herpesviridae Infections / Q000276:immunology / Q000517:prevention & control; D004854:Herpesvirus 4, Human / Q000276:immunology*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000494:pharmacology*; D007223:Infant; D016030:Kidney Transplantation / Q000009:adverse effects / Q000276:immunology*; D014412:Tumor Virus Infections / Q000276:immunology / Q000517:prevention & control
D016756:Immunoglobulins, Intravenous